ArticleDigestive diseases and sciences2026

PODXL2 Promotes Cholangiocarcinoma Progression via Interactions with Ezrin and Activation of the MAPK/ERK1/2 and PI3K/AKT Signaling Pathways.

Yu Meng et al.PubMed ↗Publisher ↗

No numbers read from the abstract.